bought 0.52... luckily

Dividend attractive.. chemicals solution company

can push to 1.00?

Already clarified the news on theedge, but theedge didn't update the real fact ...

Next qr should be good.. get orders from big brand

malton get bandar msia project ... ?

ts wong didnt buy back?

YSP Southeast Asia Holding Bhd
(Nov 20, RM2.50)
Maintain buy with an unchanged target price (TP) of RM3: Despite recording a weaker third quarter of financial year 2019 (3QFY19) core net profit (CNP) (-9% year-on-year [y-o-y]), YSP Southeast Asia Holding Bhd’s y-o-y earnings contraction has narrowed, while earnings were actually stronger on a quarter-on-quarter (q-o-q) basis. This was despite 3Q typically being a seasonally weak quarter. This reaffirms our view that YSP is on the road to recovery as its new equipment is running at more efficient rates. We maintain our earnings forecasts and reiterate our “buy” call on YSP with an unchanged TP of RM3.


YSP reported a flattish revenue of RM74 million (+1% y-o-y) for 3QFY19 as the growth in domestic sales (+3% y-o-y) was offset by soft overseas sales (-4% y-o-y). While its CNP continued to decline by 9% y-o-y, we think the results are showing signs of recovery as the y-o-y earnings contraction narrowed to only -9% for 3QFY19 from an average -36% for the past three consecutive quarters, despite the unfavourable foreign exchange rate in 3Q19 (3Q18: RM4.09/US$ versus 3Q19: RM4.16/US$). We believe this was mainly due to an improvement in margins as its new equipment is running at more efficient rates. The results were in line with expectations.

Sequentially, YSP’s CNP recorded a significant 19% improvement for 3QFY19. Based on the historical three-year average data, 3Q is typically a seasonally weak quarter, making up only 18%-19% of its profit before tax and CNP.

With both the narrowed y-o-y decline in CNP and the q-o-q improvement in 3QFY19, we think that YSP is on the road to recovery following the initial start-up expenses for its new equipment which it incurred in the past few quarters. We continue to expect margins to improve gradually in the coming quarters.

We maintain our earnings forecasts, “buy” rating and TP of RM3, based on an unchanged target price-earnings ratio of 14 times. Downside risks include weakening of the ringgit against the US dollar, product recalls and regulatory risks. — Affin Hwang Capital, Nov 20

yspsah is still strong....

coming 1.20?

possible gg?

should be up .. due to pharma

can sell 0.07?

should back to 80 sens

good point to collect??

possible to close at 0.40 today?

prepare to buy back

Scicom getting Skin project

Ready to shoot ?

strong company.. can keep

Ex date soon.. dividend 0.085

52 weeks low... value buy

Still can buy ?

This stock can buy ?

ts wong counter.. should goreng till 0.45 above ... :)

Will break 0.37 resistance ?

Buy now lor.. will go back to 0.60 above very soon

Undervalued stock, collect now before it boom to 0.54

Start moving? Towards 0.50?

Last chance to buy at 0.48

No more power go up?

Should break 0.50 then fly. Ssd is the future

Resistance :0.46 , Support  : 0.43,
Target Price : 0.55   Stop Loss  : 0.445

resistance 0.69, support 0.65, stop loss 0.563, target price 0.70

tomorrow wake up

Undervalued stock. Ideal price should be 0.60

today no trade?

Any moving?

0.505 operators entered again, prepare to push up to 0.55

another undervalued counter. same as wct. bought 1000 lots at 0.545

bought 1000 lots at 0.945

048 crocs bought。current price now is undervalue

096 sold please

break 0.46 then will fly . tp 0.50

possible to break 0.58?

down again

should go up to 0.58 later

can push to 1.50?

will break 0.55

good news coming